India iPS Cell-Derived Organoids: Advancing Regenerative Medicine and Biomedical Research
India is emerging as a dynamic hub in the field of regenerative medicine and stem cell research, and one of the most promising frontiers in this domain is the development of induced pluripotent stem (iPS) cell-derived organoids. These miniature, three-dimensional tissue models mimic the structural and functional properties of human organs, offering revolutionary opportunities for drug discovery, personalized medicine, and disease modeling. As the country invests heavily in biotechnology and translational research, iPS cell-derived organoids are expected to reshape the future of healthcare and biological innovation in India.
iPS cells are generated by reprogramming adult somatic cells into a pluripotent state—meaning they can differentiate into virtually any type of human cell. When cultivated under specific laboratory conditions, these cells can self-organize into organ-like structures known as organoids. This technology bridges a critical gap between traditional cell cultures and animal models,…